160 related articles for article (PubMed ID: 34123414)
1. The Analysis of Dynamic Changes and Prognosis of Posner-Schlossman Syndrome with Cytomegalovirus Infection and Antiviral Therapy.
Sheng Q; Zhai R; Fan X; Kong X
J Ophthalmol; 2021; 2021():6687929. PubMed ID: 34123414
[TBL] [Abstract][Full Text] [Related]
2. [Effect of 2% ganciclovir eye drops on cytomegalovirus positive Posner-Schlossman syndrome].
Zhai RY; Xu H; Kong XM; Wang ZJ
Zhonghua Yan Ke Za Zhi; 2018 Nov; 54(11):833-838. PubMed ID: 30440154
[No Abstract] [Full Text] [Related]
3. 2% Ganciclovir Eye Drops Control Posner-Schlossman Syndrome Relapses With/Without Cytomegalovirus Intraocular Reactivation.
Sheng Q; Zhai R; Fan X; Kong X
Front Med (Lausanne); 2022; 9():848820. PubMed ID: 35355609
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy.
Su CC; Hu FR; Wang TH; Huang JY; Yeh PT; Lin CP; Wang IJ
Am J Ophthalmol; 2014 Nov; 158(5):1024-1031.e2. PubMed ID: 25124264
[TBL] [Abstract][Full Text] [Related]
5. [Determination of cytomegalovirus IgG synthesis by the albumin correction in the aqueous humor of posner-schlossmann syndrome].
Wang XL; Wang ZJ; Tang L; Cao WW; Sun XH
Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):104-108. PubMed ID: 28260360
[No Abstract] [Full Text] [Related]
6. Relationships between the clinical characteristics and copy numbers of DNA of cytomegalovirus determined by real-time PCR.
Yoshimura A; Araki-Sasaki K; Toyokawa N; Fujiwara R; Jho N; Gomi F
Int Ophthalmol; 2020 Sep; 40(9):2297-2305. PubMed ID: 32418075
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of virus-related uveitic secondary glaucoma: focus on cytomegalovirus and varicella zoster virus.
Fan X; Li Z; Zhai R; Sheng Q; Kong X
BMC Ophthalmol; 2022 Mar; 22(1):130. PubMed ID: 35317777
[TBL] [Abstract][Full Text] [Related]
8. 2% Ganciclovir Controlled Posner-Schlossman Syndrome Relapse and Reduced the Chance of Corticosteroid Dependence: A Large Cohort in East China.
Sheng Q; Sun Y; Zhai R; Fan X; Ying Y; Kong X
Ocul Immunol Inflamm; 2023 Jul; ():1-8. PubMed ID: 37437131
[TBL] [Abstract][Full Text] [Related]
9. Steroid-Dependency in Posner-Schlossman Syndrome: A Suggested Topical 2% Ganciclovir and Gradual Decrement of Topical Steroid Combination Therapy from Shanghai PSS Study.
Ying Y; Sun Y; Sheng Q; Zhai R; Fan X; Kong X
Ocul Immunol Inflamm; 2023 Sep; ():1-7. PubMed ID: 37703505
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus-positive corneal stromal edema with keratic precipitates after penetrating keratoplasty: a case-control study.
Chee SP; Jap A; Ling EC; Ti SE
Cornea; 2013 Aug; 32(8):1094-8. PubMed ID: 23538617
[TBL] [Abstract][Full Text] [Related]
11. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes.
Chee SP; Jap A
Am J Ophthalmol; 2008 Dec; 146(6):883-9.e1. PubMed ID: 19027423
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Topical Ganciclovir and Corticosteroid on Cytomegalovirus Corneal Endotheliitis in Korean Patients.
Hwang JH; Ha M; Park Y; Chung SH
Ocul Immunol Inflamm; 2019; 27(2):338-344. PubMed ID: 29953306
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of an extemporaneous preparation of 2% ganciclovir eye drops in CMV anterior uveitis.
Keorochana N; Choontanom R
BMJ Open Ophthalmol; 2017; 2(1):e000061. PubMed ID: 29354718
[TBL] [Abstract][Full Text] [Related]
14. Analysis of risk factors associated with secondary open-angle glaucoma in Posner-Schlossman syndrome: A retrospective case-control study.
Li J; Ji Y; Yang W; Yao Y; Wang S; Zhang Z; Yao J; Li K
Front Med (Lausanne); 2022; 9():1064449. PubMed ID: 36698797
[TBL] [Abstract][Full Text] [Related]
15. Construction of a mouse model of Posner-Schlossman syndrome by anterior chamber infection with cytomegalovirus.
Liu X; Wang H; Ma L; Ying M; Liu Q; Chang H; Jin S; Yang F; Zhu X; Sun X; Xu F; Liu H
Exp Eye Res; 2022 May; 218():109009. PubMed ID: 35276185
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features of Glaucoma Associated with Cytomegalovirus Corneal Endotheliitis.
Mori K; Ye Y; Yokogawa H; Nishino T; Kobayashi A; Mori N; Takemoto Y; Sugiyama K
Clin Ophthalmol; 2022; 16():2705-2711. PubMed ID: 36017508
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of anterior uveitis caused by three different herpes viruses.
Sakai JI; Usui Y; Suzuki J; Kezuka T; Goto H
Int Ophthalmol; 2019 Dec; 39(12):2785-2795. PubMed ID: 31134426
[TBL] [Abstract][Full Text] [Related]
18. The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis.
Koizumi N; Miyazaki D; Inoue T; Ohtani F; Kandori-Inoue M; Inatomi T; Sotozono C; Nakagawa H; Horikiri T; Ueta M; Nakamura T; Inoue Y; Ohashi Y; Kinoshita S
Br J Ophthalmol; 2017 Feb; 101(2):114-119. PubMed ID: 27142389
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Topical Ganciclovir and Corticosteroids Preserve Corneal Endothelial Function in Cytomegalovirus Corneal Endotheliitis.
Fan NW; Chung YC; Liu YC; Liu CJ; Kuo YS; Lin PY
Cornea; 2016 May; 35(5):596-601. PubMed ID: 26967107
[TBL] [Abstract][Full Text] [Related]
20. Effects of ROCK Inhibitors on Apoptosis of Corneal Endothelial Cells in CMV-Positive Posner-Schlossman Syndrome Patients.
Igarashi N; Honjo M; Kaburaki T; Aihara M
Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):5. PubMed ID: 32749463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
